$1.4 Million Grant Funds Study of Drug Candidates for Neurological Disorders and Other Diseases

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $1.4 million from the National Institute of Mental Health of the National Institutes of Health (NIH) to explore the development of drug candidates for a wide range of conditions, including circadian rhythm disorders.

Patrick R. Griffin, chair of the Department of Molecular Therapeutics at Scripps Florida, and Kamenecka Kamenecka, a TSRI associate professor, will be the principal investigators of the new three-year grant.

The project involves what are known as RORs (retinoic acid receptor-related orphan receptors), a class of molecules that plays a role in the expression of genes involved in carbohydrate and fat metabolism, inflammation and circadian rhythm. Disruptions in circadian rhythm—the pattern of activity and rest over a 24-hour daily cycle—have been associated with depression, bipolar disease and schizophrenia.

“While the functions of other ROR receptors have been widely studied, little is known about RORbeta,” Griffin said. “The new grant will allow us to expand and improve our experimental compounds to study RORbeta function in depth. This line of research should increase our understanding of this receptor as well as circadian rhythm and related disorders.”

While not specifically aimed at producing drug candidates, Griffin said, the new research will include studies of the new optimized compounds in experimental models of a range of diseases.

The number of the grant is 1R01MH108173.

Send comments to: press[at]scripps.edu

griffin
“The new grant will allow us to expand and improve our experimental compounds to study RORbeta function in depth,” says Patrick Griffin, chair of the Department of Molecular Therapeutics. (Photo by Lucien Capehart.)

Associate Professor Theodore Kamenecka will co-lead the new grant with Griffin. (Photo by Lucien Capehart.)

SEARCH NEWS & VIEWS

Team Finds Better Way to Engineer Therapeutic Proteins into Antibodies

International Team Discovers the Ancient Origins of Deadly Lassa Virus

Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms

Collaboration Leads to First Structure of Crucial Plant Hormone

Hands-On Research 101: Internships Introduce Undergrads to Biomedical Science in Action

$1.4 Million Grant Funds Study of Drug Candidates for Neurological Disorders and Other Diseases

$1.4 Million Grant Funds Study of Drug Candidates for Neurological Disorders and Other Diseases